文献速递急性肾损伤慢性肾脏病

髓系IRF4缺失通过减少巨噬细胞募集与活化保护缺血性肾损伤后纤维化

Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation.
PubMed 文献 · J Am Soc Nephrol · 2021-02-22

该研究用髓系或巨噬细胞特异性敲除Irf4的小鼠(MΦ Irf4-/-)评估IRF4在严重AKI后肾巨噬细胞极化和纤维化中的作用。结果显示,巨噬细胞Irf4缺失对AKI早期肾功能恢复影响极小,但显著减少严重AKI后4周肾纤维化,并与巨噬细胞活化减少相关;机制涉及AKT/PI3K通路抑制单核细胞募集。

要点

  • 巨噬细胞Irf4缺失不影响AKI早期肾功能恢复,但减少4周后肾纤维化。
  • Irf4缺失降低骨髓来源单核细胞趋化反应,与AKT/PI3K活化下降、PTEN表达增加相关。
  • 抑制AKT活性可减少野生型小鼠AKI后肾巨噬细胞浸润。

核心结论

  • 髓系细胞Irf4缺失通过抑制AKT介导的单核细胞募集及减少活化和促纤维化M2极化,保护严重缺血性肾损伤后肾小管间质纤维化。

研究设计与样本

  • 使用髓系或巨噬细胞特异性敲除Irf4的小鼠(MΦ Irf4-/-)评估IRF4在严重AKI后肾巨噬细胞极化和纤维化中的作用。

主要发现

  • 巨噬细胞Irf4缺失对AKI早期肾功能恢复影响极小,但减少严重AKI后4周肾纤维化,并与巨噬细胞活化减少相关。
  • 巨噬细胞Irf4缺失也在单侧输尿管梗阻中防止肾纤维化。
  • MΦ Irf4-/-小鼠骨髓来源单核细胞对巨噬细胞趋化剂的趋化反应减弱,伴随AKT和PI3K活化下降及PTEN表达增加。
  • PI3K和AKT抑制剂显著降低野生型骨髓来源单核细胞及培养巨噬细胞系的趋化性。
  • 标记的Irf4-/-骨髓来源单核细胞向缺血后肾脏归巢显著受抑;MΦ Irf4-/-小鼠或抑制AKT活性的野生型小鼠AKI后肾巨噬细胞浸润显著减少。

临床怎么用

  • 提示靶向髓系IRF4或其下游AKT/PI3K通路可能减轻严重AKI后肾纤维化进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: AKI is characterized by abrupt and reversible kidney dysfunction, and incomplete recovery leads to chronic kidney injury. Previous studies by us and others have indicated that macrophage infiltration and polarization play key roles in recovery from AKI. The role in AKI recovery played by IFN regulatory factor 4 (IRF4), a mediator of polarization of macrophages to the M2 phenotype, is unclear. METHODS: We used mice with myeloid or macrophage cell-specific deletion of Irf4 (MΦ Irf4-/- ) to evaluate Irf4's role in renal macrophage polarization and development of fibrosis after severe AKI. RESULTS: Surprisingly, although macrophage Irf4 deletion had a minimal effect on early renal functional recovery from AKI, it resulted in decreased renal fibrosis 4 weeks after severe AKI, in association with less-activated macrophages. Macrophage Irf4 deletion also protected against renal fibrosis in unilateral ureteral obstruction. Bone marrow-derived monocytes (BMDMs) from MΦ Irf4-/- mice had diminished chemotactic responses to macrophage chemoattractants, with decreased activation of AKT and PI3 kinase and increased PTEN expression. PI3K and AKT inhibitors markedly decreased chemotaxis in wild-type BMDMs, and in a cultured macrophage cell line. There was significant inhibition of homing of labeled Irf4-/- BMDMs to postischemic kidneys. Renal macrophage infiltration in response to AKI was markedly decreased in MΦ Irf4-/- mice or in wild-type mice with inhibition of AKT activity. CONCLUSIONS: Deletion of Irf4 from myeloid cells protected against development of tubulointerstitial fibrosis after severe ischemic renal injury in mice, due primarily to inhibition of AKT-mediated monocyte recruitment to the injured kidney and reduced activation and subsequent polarization into a profibrotic M2 phenotype.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sasaki K, Terker AS, Pan Y, et al. Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation. J Am Soc Nephrol. 2021. PMID: 33619052. doi:10.1681/ASN.2020071010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。